InflaRx competitors

InflaRx Competitors include Bellerophon Therapeutics, Heron Therapeutics , La Renon and CorMedix.
Add company...
InflaRx
InflaRx
InflaRx develops new therapeutics in the field of acute and chronic inflammation.
Bellerophon Therapeutics
Bellerophon Therapeutics
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform.
La Renon
La Renon
An Indian Pharma House with the motto of Creating a Healthy World converting Science into high end formulations for Chronic illnesses and diseases.
CorMedix
CorMedix
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
Founding Date
Founding Date
2006
Founding Date
2009
Founding Date
1983
Founding Date
2007
Founding Date
2006
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Jena, DE HQ
Planegg, DE
Locations
Warren, US HQ
Locations
San Diego, US HQ
Jersey City, US
Locations
Ahmedabad, IN HQ
Locations
Bedminster Township, US HQ
Employees
Employees
9
Employees
209% decrease
Employees
1454% increase
Employees
3863% increase
Employees
14
Valuation ($)
Valuation ($)
765.1 m
Valuation ($)
65.1 m
Valuation ($)
2.1 b
Valuation ($)
N/A
Valuation ($)
158 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
138
Twitter followers
620

Financial

Revenue (est.)
Revenue (est.)
€108k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$329.3k (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$4.6m (FY, 2017)
Cost of goods
N/A
Cost of goods
$115k (FY, 2017)
Net income
Net income
(€24.2m) (FY, 2017)
Net income
($54.8m) (FY, 2017)
Net income
($197.5m) (FY, 2017)
Net income
N/A
Net income
($33m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 80m
Total funding raised
N/A
Total funding raised
$ 16m
Total funding raised
$ 11.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Bellerophon Therapeutics
HQ
Warren, US
Employees
20↓ 9% decrease

Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases.

View company
Heron Therapeutics
HQ
San Diego, US
Employees
145↑ 4% increase

Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform.

View company
La Renon
HQ
Ahmedabad, IN
Employees
386↑ 3% increase

An Indian Pharma House with the motto of Creating a Healthy World converting Science into high end formulations for Chronic illnesses and diseases.

View company
CorMedix
HQ
Bedminster Township, US
Employees
14

CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.

View company